The Cas nuclease market is on an upward trajectory, forecasted to grow from $2.75 billion in 2023 to $3.27 billion in 2024, at a CAGR of 18.9%. Key drivers include the rapid advancements in genome ...
Agilent Technologies or Inc. because you’re not sure how they measure up ... and other research and industrial markets, as well as clinical laboratories. The company’s Specialty Diagnostics segment ...
S&P 500 Shake-Up: New Entrants Driving Market Momentum The S&P 500 is a widely recognized benchmark for the US stock market, and it has undergone reshuffling due to the quarterly rebalancing ...